Without the Neuropeptide VIP, the Brain's Master Clock Neurons Lose Their Day-Night Rhythm
Loss of VIP-VPAC2 receptor signaling disrupted coordinated day-night variation in SCN neuron excitability, caused neurons to manifest random electrical states, and impaired responses to light-input signals.
Quick Facts
What This Study Found
VPAC2 receptor knockout mice exhibited loss of coordinated day-night variation in SCN neuronal excitability, with neurons manifesting random electrical states, lacking voltage-gated sodium current components, and showing altered responses to light-pathway input signals.
Key Numbers
Recordings captured day-night variation in neuronal excitability across the circadian cycle in both knockout and wild-type mice.
How They Did This
Patch-clamp electrophysiology recordings from SCN neurons in brain slices from Vipr2-/- (VPAC2 knockout) and Vipr2+/+ (wild-type) mice across the circadian cycle, measuring membrane properties, action potential thresholds, voltage-gated sodium currents, and responses to neurochemical mimics of light input.
Why This Research Matters
VIP is one of the most important neuropeptides in circadian biology. Understanding how it coordinates clock neuron activity could lead to treatments for circadian rhythm disorders, jet lag, shift work problems, and the many diseases linked to disrupted body clocks (metabolic syndrome, depression, cancer risk).
The Bigger Picture
Circadian disruption is linked to obesity, diabetes, depression, cardiovascular disease, and even cancer. VIP-VPAC2 signaling is the master synchronizer of the body clock. This study shows exactly what goes wrong at the single-neuron level when that synchronization fails — providing potential therapeutic targets for the many diseases associated with circadian rhythm disruption.
What This Study Doesn't Tell Us
Complete genetic knockout of VPAC2 is more extreme than any natural variation in VIP signaling — results may overestimate the impact of partial VIP dysfunction. Mouse SCN organization may differ from humans. Brain slice preparations remove the SCN from its normal context, though this is standard methodology.
Questions This Raises
- ?Could drugs that enhance VIP-VPAC2 signaling help resynchronize disrupted circadian rhythms in shift workers?
- ?Do partial reductions in VIP signaling (as might occur with aging) produce intermediate disruptions in SCN coordination?
- ?Is the missing sodium current component a direct consequence of VPAC2 loss or a downstream developmental effect?
Trust & Context
- Key Stat:
- Loss of coordinated day-night variation Without VPAC2 receptors, SCN neurons displayed random electrical states at both day and night instead of the synchronized rhythm seen in normal mice
- Evidence Grade:
- Preliminary evidence from a rigorous electrophysiology study using genetic knockout mice. The findings are mechanistically clear but translation to human circadian disorders requires further research.
- Study Age:
- Published in 2024, advancing our understanding of the molecular basis of circadian timekeeping in the SCN.
- Original Title:
- Loss of neuropeptide signalling alters temporal expression of mouse suprachiasmatic neuronal state and excitability.
- Published In:
- The European journal of neuroscience, 60(11), 6617-6633 (2024)
- Authors:
- Wegner, Sven, Belle, Mino D C, Chang, Pi-Shan, Hughes, Alun T L, Conibear, Alexandra E, Muir, Charlotte, Samuels, Rayna E, Piggins, Hugh D
- Database ID:
- RPEP-09514
Evidence Hierarchy
Frequently Asked Questions
What does VIP do in the brain's clock?
VIP (vasoactive intestinal peptide) is a neuropeptide that acts as a synchronization signal between clock neurons in the SCN — the brain's master timekeeper. Each SCN neuron has its own internal clock, but without VIP they drift out of sync, like an orchestra without a conductor. VIP, working through VPAC2 receptors, keeps all the neurons firing in coordinated day-night patterns so your body functions stay properly timed.
Could problems with VIP explain why some people have trouble with sleep schedules?
It's possible. While complete VIP signaling loss (as in this study's knockout mice) is extreme, reduced VIP function — which may happen with aging — could contribute to weaker circadian rhythms and greater sensitivity to disruption from jet lag, shift work, or irregular schedules. Research is still connecting these molecular findings to real-world sleep and circadian disorders in humans.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09514APA
Wegner, Sven; Belle, Mino D C; Chang, Pi-Shan; Hughes, Alun T L; Conibear, Alexandra E; Muir, Charlotte; Samuels, Rayna E; Piggins, Hugh D. (2024). Loss of neuropeptide signalling alters temporal expression of mouse suprachiasmatic neuronal state and excitability.. The European journal of neuroscience, 60(11), 6617-6633. https://doi.org/10.1111/ejn.16590
MLA
Wegner, Sven, et al. "Loss of neuropeptide signalling alters temporal expression of mouse suprachiasmatic neuronal state and excitability.." The European journal of neuroscience, 2024. https://doi.org/10.1111/ejn.16590
RethinkPeptides
RethinkPeptides Research Database. "Loss of neuropeptide signalling alters temporal expression o..." RPEP-09514. Retrieved from https://rethinkpeptides.com/research/wegner-2024-loss-of-neuropeptide-signalling
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.